{"id":8980,"date":"2023-05-25T17:38:19","date_gmt":"2023-05-25T17:38:19","guid":{"rendered":"https:\/\/nau.edu\/sherc\/?page_id=8980"},"modified":"2025-10-01T17:46:15","modified_gmt":"2025-10-01T17:46:15","slug":"ppp-year-1-hepp","status":"publish","type":"page","link":"https:\/\/in.nau.edu\/sherc\/ppp-year-1-hepp\/","title":{"rendered":"PPP Year 1: Hepp Characterization of populations linked to Neonatal Abstinence Syndrome: Infants with NAS and their mothers"},"content":{"rendered":"
Opioid utilization during pregnancy can result in newborn infants experiencing drug withdrawal symptoms, called Neonatal Abstinence Syndrome (NAS), within 24-48 hours of birth. In 2012, hospital costs associated with NAS births were approximately $1.5 billion, and 81 percent of these charges were paid by Medicaid.<\/p>\n
We estimate that the current NAS incidence in Arizona is 10 per 1,000 births, which is quite high, considering that the nationwide incidence in 2013 was 6 per 1,000 births. Despite this worrisome statistic, little is known about the population characteristics of these infants and their mothers, which is partially due to lack of reporting.<\/p>\n
However, Governor Ducey released the Declaration of Emergency and Notification of Enhanced Surveillance Advisory\u2014Opioid Overdose Epidemic, and NAS reporting is now required, across the state, within 24 hours of an event.<\/p>\n
The researchers used these new data to accomplish the overarching goal of better understanding which groups of infants disproportionately experience NAS, during the reporting time frame of June 15, 2017- June 15, 2018.<\/p>\n
To achieve this goal, they carried out the following aims:<\/p>\n
Given the dearth of information on this topic, we anticipate the proposed research will pave the way for local interventions while having national, and even global, implications.<\/p>\n
Funding:<\/strong> The study is funded by NIMHD\/NIH U54MD012388<\/p>\n
\nAbout the investigator<\/h2>\n